CN Patent

CN106905245A — 2,4-二取代的嘧啶类化合物

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2017-06-30 · 9y expired

What this patent protects

本发明属于医药化学领域，涉及2,4-二取代的嘧啶类化合物，具体涉及如式(I)所示的化合物或其药学上可接受的盐、其药物组合物、及其在治疗EGFR或/和ALK介导的疾病中的用途。

USPTO Abstract

本发明属于医药化学领域，涉及2,4-二取代的嘧啶类化合物，具体涉及如式(I)所示的化合物或其药学上可接受的盐、其药物组合物、及其在治疗EGFR或/和ALK介导的疾病中的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN106905245A
Jurisdiction: CN
Classification: —
Expires: 2017-06-30
Drug substance claim: No
Drug product claim: No
Assignee: Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.